COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 197 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,677 | +15.0% | 970 | +10.6% | 0.00% | – |
| Q2 2023 | $18,843 | -91.9% | 877 | -91.0% | 0.00% | – |
| Q1 2023 | $233,805 | +64.7% | 9,751 | +59.9% | 0.00% | – |
| Q4 2022 | $142,000 | +52.7% | 6,099 | +4.3% | 0.00% | – |
| Q3 2022 | $93,000 | +564.3% | 5,846 | +620.8% | 0.00% | – |
| Q2 2022 | $14,000 | -12.5% | 811 | 0.0% | 0.00% | – |
| Q1 2022 | $16,000 | +33.3% | 811 | +17.4% | 0.00% | – |
| Q4 2021 | $12,000 | -40.0% | 691 | -33.5% | 0.00% | – |
| Q3 2021 | $20,000 | -25.9% | 1,039 | -9.6% | 0.00% | – |
| Q2 2021 | $27,000 | +8.0% | 1,149 | +7.2% | 0.00% | – |
| Q1 2021 | $25,000 | -16.7% | 1,072 | -30.4% | 0.00% | – |
| Q4 2020 | $30,000 | +30.4% | 1,541 | +35.3% | 0.00% | – |
| Q3 2020 | $23,000 | -8.0% | 1,139 | -18.4% | 0.00% | – |
| Q2 2020 | $25,000 | +127.3% | 1,395 | +104.5% | 0.00% | – |
| Q1 2020 | $11,000 | – | 682 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,887,332 | $34,840,000 | 5.65% |
| SECTORAL ASSET MANAGEMENT INC | 1,426,862 | $26,340,000 | 3.29% |
| Eventide Asset Management | 2,207,610 | $40,752,000 | 2.12% |
| Rock Springs Capital Management LP | 1,885,729 | $34,811,000 | 1.58% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 460,000 | $8,492,000 | 1.11% |
| Cormorant Asset Management, LP | 300,000 | $5,538,000 | 0.58% |
| HIGHLAND CAPITAL MANAGEMENT LP | 579,234 | $10,693,000 | 0.49% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,389,863 | $25,657,000 | 0.39% |
| NBW CAPITAL LLC | 69,050 | $1,275,000 | 0.34% |
| NEXT CENTURY GROWTH INVESTORS LLC | 144,972 | $2,676,000 | 0.33% |